Insider buying
~$16K7,172 sh @ $2.28
Traded Sep 22, 2025 · filed 1 day later
The CEO of Filana Therapeutics paid $16K out of pocket for Filana Therapeutics shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 19, 2025 · Filed Sep 22, 2025
The CEO of Filana Therapeutics paid $900 out of pocket for Filana Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$900
Shares × reported transaction price
<$25K
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
+0.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the CEO's reported total pay for fiscal 2024 ($16.7M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-28. The proxy names this person as CEO for that year. A size comparison, not a judgement
36 days after results of Aug 14, 2025, 54 days before results of Nov 12, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Sep 22, 2025 · filed 1 day later
The CEO of Filana Therapeutics paid $16K out of pocket for Filana Therapeutics shares.
Insider buying
Traded Sep 19, 2025 · filed 3 days later
The CEO of Filana Therapeutics paid $107K out of pocket for Filana Therapeutics shares. Shares held went up 7% with this purchase.
Insider buying
First insider buy since Aug 2023Traded Sep 18, 2025 · filed 4 days later
The CEO of Filana Therapeutics paid $415K out of pocket for Filana Therapeutics shares. Shares held went up 39% with this purchase.